119
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Fucoidan Ameliorates Hepatocellular Carcinoma Induced in Rats: Effect on miR143 and Inflammation

, , , & ORCID Icon
Pages 1498-1510 | Received 19 Feb 2020, Accepted 30 Jun 2020, Published online: 28 Jul 2020

References

  • Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017; 24(3):1073274817729245. doi:10.1177/1073274817729245
  • Zhan T, Sollors J, Steinebrunner N, Schlitt HJ, Stroszczynski C, Weiss KH, Ebert MP, Teufel A. Pharmacological treatment of hepatocellular carcinoma with cavoatrial tumor thrombus - Case series and literature review. Z Gastroenterol. 2019;57(4):501–507. doi:10.1055/a-0855-4469
  • Al-Gayyar MMH, Bagalagel A, Noor AO, Almasri DM, Diri R. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Biomed Pharmacother. 2019;112:108653. doi:10.1016/j.biopha.2019.108653
  • Su Z-X, Zhao J, Rong Z-H, Geng W-M, Wu Y-G, Qin C-K. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma. Diagn Pathol. 2014;9(1):47. doi:10.1186/1746-1596-9-47
  • Trakooljul N, Hicks JA, Liu HC. Identification of target genes and pathways associated with chicken microRNA miR-143. Anim Genet. 2010;41(4):357–364. doi:10.1111/j.1365-2052.2009.02015.x
  • Zhang Z-q, Meng H, Wang N, Liang L-n, Liu L-n, Lu S-m, Luan Y. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma. Diagn Pathol. 2014;9(1):135. doi:10.1186/1746-1596-9-135
  • Wu L, Sun J, Su X, Yu Q, Yu Q, Zhang P. A review about the development of fucoidan in antitumor activity: Progress and challenges. Carbohydr Polym. 2016;154:96–111. doi:10.1016/j.carbpol.2016.08.005
  • Deepika MS, Thangam R, Sheena TS, Sasirekha R, Sivasubramanian S, Babu MD, Jeganathan K, Thirumurugan R. A novel rutin-fucoidan complex based phytotherapy for cervical cancer through achieving enhanced bioavailability and cancer cell apoptosis. Biomed Pharmacother. 2019;109:1181–1195. doi:10.1016/j.biopha.2018.10.178
  • Collins K, Fitzgerald G, Stanton C, Ross R. Looking beyond the terrestrial: The potential of seaweed derived bioactives to treat non-communicable diseases. Mar Drugs 2016; 14(3):60. doi:10.3390/md14030060
  • Amin ML, Mawad D, Dokos S, Koshy P, Martens PJ, Sorrell CC. Immunomodulatory properties of photopolymerizable fucoidan and carrageenans. Carbohydr Polym. 2020; 230:115691. doi:10.1016/j.carbpol.2019.115691
  • Lin Y, Qi X, Liu H, Xue K, Xu S, Tian Z. The anti-cancer effects of fucoidan: A review of both in vivo and in vitro investigations. Cancer Cell Int. 2020;20:154. doi:10.1186/s12935-020-01233-8
  • Cho Y, Yoon J-H, Yoo J-J, Lee M, Lee DH, Cho EJ, Lee J-H, Yu SJ, Kim YJ, Kim CY, et al. Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharm Sin B. 2015;5(6):544–553. doi:10.1016/j.apsb.2015.09.004
  • Yan M-D, Yao C-J, Chow J-M, Chang C-L, Hwang P-A, Chuang S-E, Whang-Peng J, Lai G-M. Fucoidan elevates microRNA-29b to regulate DNMT3B-MTSS1 axis and inhibit EMT in human hepatocellular carcinoma cells. Mar Drugs 2015;13(10):6099–6116. doi:10.3390/md13106099
  • Yang L, Wang P, Wang H, Li Q, Teng H, Liu Z, Yang W, Hou L, Zou X. Fucoidan derived from Undaria pinnatifida induces apoptosis in human hepatocellular carcinoma SMMC-7721 cells via the ROS-mediated mitochondrial pathway. Mar Drugs 2013;11(6):1961–1976. doi:10.3390/md11061961
  • Takahashi H, Kawaguchi M, Kitamura K, Narumiya S, Kawamura M, Tengan I, Nishimoto S, Hanamure Y, Majima Y, Tsubura S, et al. An exploratory study on the anti-inflammatory effects of fucoidan in relation to quality of life in advanced cancer patients. Integr Cancer Ther. 2018;17(2):282–291. Jundoi:10.1177/1534735417692097
  • Al-Gayyar MM, Abbas A, Hamdan AM. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma. Biol Chem. 2016;397(3):257–267. doi:10.1515/hsz-2015-0265
  • Nazmy EA, El-Khouly OA, Zaki MMA, Elsherbiny NM, Said E, Al-Gayyar MMH, Salem HA. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats. Environ Toxicol Pharmacol. 2019;72:103240. doi:10.1016/j.etap.2019.103240
  • Sherif IO, Al-Gayyar M. Oleuropein potentiates anti-tumor activity of cisplatin against HepG2 through affecting proNGF/NGF balance. Life Sci. 2018;198:87–93. doi:10.1016/j.lfs.2018.02.027
  • Angelidakis G, Krishnan S, Cabrera NL, Jiang Y, Pushparaji B, Kaseb A, Torres HA. Virologic impact of radiotherapy in hepatitis C virus-infected patients with hepatocellular carcinoma. Hepatology 2020. doi:10.1002/hep.31114
  • Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009;50(2):490–499. doi:10.1002/hep.23008
  • Bae H, Lee J-Y, Yang C, Song G, Lim W. Fucoidan derived from Fucus vesiculosus inhibits the development of human ovarian cancer via the disturbance of calcium homeostasis, endoplasmic reticulum stress, and angiogenesis. Mar Drugs 2020;18(1):45. doi:10.3390/md18010045
  • Van Weelden G, Bobiński M, Okła K, Van Weelden WJ, Romano A, Pijnenborg JMA. Fucoidan structure and activity in relation to anti-cancer mechanisms. Mar Drugs 2019;17(1):32. doi:10.3390/md17010032
  • Duan Y, Li J, Jing X, Ding X, Yu Y, Zhao Q. Fucoidan induces apoptosis and inhibits proliferation of hepatocellular carcinoma via the p38 MAPK/ERK and PI3K/Akt signal pathways. Cancer Manag Res. 2020;12:1713–1723. doi:10.2147/CMAR.S243495
  • Shi W, Hu J, Zhu S, et al. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis. Int J Clin Exp Pathol. 2015;8(10):13083–13089.
  • Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma. J Gastrointestin Liver Dis. 2008;17(4):411–477.
  • Alyoussef A, Al-Gayyar M. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother. 2018;103:362–372. doi:10.1016/j.biopha.2018.04.060
  • Hamdan AM, Al-Gayyar MM, Shams MEE, Alshaman US, Prabahar K, Bagalagel A, Diri R, Noor AO, Almasri D. Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives. Sci Rep. 2019;9(1):7026. doi:10.1038/s41598-019-43568-x
  • Wang Y-Q, Wei J-G, Tu M-J, Gu J-G, Zhang W. Fucoidan alleviates acetaminophen-induced hepatotoxicity via oxidative stress inhibition and Nrf2 translocation. IJMS. 2018;19(12):4050. doi:10.3390/ijms19124050
  • Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice. Int J Biol Macromol. 2018;112:929–236. doi:10.1016/j.ijbiomac.2018.02.072
  • Abdel-Daim MM, Abushouk AI, Bahbah EI, Bungău SG, Alyousif MS, Aleya L, Alkahtani S. Fucoidan protects against subacute diazinon-induced oxidative damage in cardiac, hepatic, and renal tissues. Environ Sci Pollut Res. 2020;27(11):11554–11564. doi:10.1007/s11356-020-07711-w
  • AlKahtane AA, Abushouk AI, Mohammed ET, ALNasser M, Alarifi S, Ali D, Alessia MS, Almeer RS, AlBasher G, Alkahtani S, et al. Fucoidan alleviates microcystin-LR-induced hepatic, renal, and cardiac oxidative stress and inflammatory injuries in mice. Environ Sci Pollut Res. 2020;27(3):2935–2944. doi:10.1007/s11356-019-06931-z
  • Meenakshi S, Umayaparvathi S, Saravanan R, Manivasagam T, Balasubramanian T. Hepatoprotective effect of fucoidan isolated from the seaweed Turbinaria decurrens in ethanol intoxicated rats. Int J Biol Macromol. 2014;67:367–372. doi:10.1016/j.ijbiomac.2014.03.042
  • Mamdouh S, Khorshed F, Aboushousha T, Hamdy H, Diab A, Seleem M, Saber M. Evaluation of Mir-224, Mir-215 and Mir-143 as serum biomarkers for HCV associated hepatocellular carcinoma. Asian Pac J Cancer Prev. 2017;18(11):3167–3171. doi:10.22034/APJCP.2017.18.11.3167
  • Xue F, Yin J, Xu L, Wang B. MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6. Exp Ther Med. 2017; 13(6):2667–2674. doi:10.3892/etm.2017.4348
  • Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018;9(6):7204–7218. doi:10.18632/oncotarget.23208
  • El Awdan SA, Amin MM, Hassan A. Cilostazol attenuates indices of liver damage induced by thioacetamide in albino rats through regulating inflammatory cytokines and apoptotic biomarkers. Eur J Pharmacol. 2018; 822:168–176. doi:10.1016/j.ejphar.2018.01.021
  • Jekarl DW, Lee S, Kwon JH, Nam SW, Kim M, Kim Y, Jang JW. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma. PLoS One 2019;14(11):e0224318. doi:10.1371/journal.pone.0224318
  • Do H, Pyo S, Sohn EH. Suppression of iNOS expression by fucoidan is mediated by regulation of p38 MAPK, JAK/STAT, AP-1 and IRF-1, and depends on up-regulation of scavenger receptor B1 expression in TNF-alpha- and IFN-gamma-stimulated C6 glioma cells. J Nutr Biochem. 2010;21(8):671–679. doi:10.1016/j.jnutbio.2009.03.013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.